γ-Tocotrienol and Prostate Cancer
Author Information
Author(s): W Yap, P N Chang, H Y Han, D T W Lee, M T Ling, Y C Wong, Y L Yap
Primary Institution: Davos Life Science Pte. Ltd., Cancer Research Laboratory, Singapore; Department of Anatomy, Cancer Biology Lab, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Hypothesis
This study aimed to identify the most potent isomer of tocotrienol for eliminating prostate cancer cells and to decipher the molecular pathway responsible for its activity.
Conclusion
γ-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways.
Supporting Evidence
- γ-Tocotrienol was found to induce apoptosis in prostate cancer cells.
- The study showed that γ-tocotrienol treatment suppressed NF-κB and EGF-R signaling pathways.
- Co-treatment with γ-tocotrienol and Docetaxel enhanced the apoptotic effect on prostate cancer cells.
- γ-Tocotrienol treatment restored E-cadherin expression, which is associated with reduced cell invasion.
Takeaway
This study found that a natural compound called γ-tocotrienol can help stop prostate cancer cells from growing and spreading.
Methodology
Prostate cancer cell lines were treated with different concentrations of γ-tocotrienol, and various assays were performed to assess cell viability, apoptosis, and invasion capabilities.
Limitations
The study primarily focused on in vitro experiments, and the effects in vivo may differ.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website